Common Stock SEC Reporting - Current
Contact Info
  • 275 Madison Avenue Avenue
  • STE #702
  • New York, NY 10016

Business Description

Update Company Profile
Financial Reporting/Disclosure
Reporting Status U.S. Reporting: SEC Reporting
Audited Financials Audited
Latest Report Mar 31, 2017 10-Q
CIK 0001553643
Fiscal Year End 6/30
OTC Marketplace OTCQB
Profile Data
SIC - Industry Classification 2834 - Pharmaceutical preparations
Incorporated In: NV, USA
Year of Inc. 2012
Employees 4 a/o Feb 22, 2017
Company Officers/Contacts
Sergio Traversa CEO
Richard M. Mangano, Ph. D Chief Scientific Officer
Company Directors
Charles Casamento
Paul Kelly
Maged Shenouda
Sergio Traversa
Company Notes
  • Formerly=Camp Nine, Inc. until 8-2014
Service Providers
Accounting/Auditing Firm
6002 Rogerdale
Suite 500
Houston, TX, 77072
United States

Legal Counsel
Hiscock & Barclay
One Park Place
300 South State Street
Syracuse, NY, 13202
United States

Investor Relations Firm
Not Available
RLMD Security Details
Share Structure
Market Value1 $10,233,925 a/o Sep 22, 2017
Authorized Shares 100,000,000 a/o Sep 30, 2016
Outstanding Shares 12,039,912 a/o May 15, 2017
-Restricted Not Available
-Unrestricted Not Available
Held at DTC Not Available
Float Not Available
Par Value Not Available
Transfer Agent(s)
Empire Stock Transfer Inc.
Shareholders of Record 165 a/o Sep 09, 2016
Short Selling Data
Short Interest 557 (-59.61%)
May 31, 2017
Significant Failures to Deliver No

1Market Value calculated only for respective security